Condition: Lupus Nephritis · Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
The aim of this research project is to better understand the origin and clinical significance of two lupus-specific "genetic signatures" (IFN signature and plasma cell signature) in patient subgroups with well-defined clinical characteristics. Our aim is to correlate these genetic signatures with cell activation profiles and the production of specific cytokines in different populations from whole blood and in short-term cultures of these circulating cells.
This description comes directly from the study's public registry record.
Frédéric Houssiau, Pr · +32 02 764 53 90 · frederic.houssiau@uclouvain.be
Farah Tamirou, Pr · +32 02 764 53 87 · farah.tamirou@uclouvain.be
Always discuss trial participation with your own doctor first.
| Cliniques universitaires Saint-Luc | Brussels, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05443516